PERSPECTA

News from every angle

Back to headlines

Truist Lowers Price Target for Alnylam Pharmaceuticals (ALNY)

Truist has adjusted its price target for Alnylam Pharmaceuticals (ALNY), lowering it from $515 to $505.

20 Apr, 21:31 — 20 Apr, 21:31
PostShare

Sources

Showing 1 of 1 sources